Abstract
Done with a good practice detailed in this paper, drug skin tests are useful for the diagnosis of drug hypersensitivities (HS). Drug patch tests can be done in all cutaneous adverse drug reactions but anaphylactic shock. Done under hospital surveillance, intradermal tests with immediate readings are useful in investigating immediate HS with beta-lactams, glycopeptides, radiocontrast media, insulins, proton pump inhibitors, platinum salts, corticosteroids, and general anesthetics. For delayed HS they are useful with beta-lactams, radiocontrast media, or heparins. For immediate HS to general anesthetics, quinolones, and beta-lactams, sensitivity of basophil activation tests ranges from 22 to 86% with a good specificity. In delayed HS, no test has a good sensitivity but combine three different cellular assays may help to overcome or bypass the assumed refractoriness of PBMC of SJS/TEN patients.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- AGEP:
-
Acute generalized exanthematous pustulosis
- AO:
-
Angioedema
- BAT:
-
Basophil activation test
- CADR:
-
Cutaneous adverse drug reactions
- DPTs:
-
Drug patch tests
- DRESS:
-
Drug reaction with systemic symptoms
- ELISpot:
-
Enzyme-Linked Immunosorbent Spot
- FDE:
-
Fixed drug eruption
- HS:
-
Hypersensitivities
- IDTs:
-
Intradermal Drug Tests
- IHS:
-
Immediate HS
- NMBA:
-
Neuromuscular blocking agents
- PBMC:
-
Peripheral blood mononuclear cells
- RCM:
-
Radiocontrast media
- SDRIFE:
-
Symmetrical drug-related intertriginous and flexural exanthema
- SJS/TEN:
-
Stevens–Johnson syndrome/toxic epidermal necrolysis
- UV:
-
Ultraviolet
References
Andrade P, Brinca A, Gonçalo M (2011) Patch testing in fixed drug eruptions--a 20-year review. Contact Dermatitis 65:195–201
Araujo L, Demoly P (2008) Macrolides allergy. Curr Pharm Des 14:2840–2862
Barbaud A (2014) Skin testing and patch testing in non-IgE-mediated drug allergy. Curr Allergy Asthma Rep 14:442–448
Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M et al (2013) A multicenter study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 168:555–562
Barbaud A, Gonçalo M, Bruynzeel D, Bircher A (2001) Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 45:321–328
Barbaud A, Trechot P, Reichert-Penetrat S, Commun N, Schmutz JL (2001) Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Dermatitis 45:265–268
Barbaud A, Waton J (2016) Systemic allergy to corticosteroids: clinical features and cross reactivity. Curr Pharm Des 22:6825–6831
Benucci M, Manfredi M, Demoly P, Campi P (2008) Injection site reactions to TNF-alpha blocking agents with positive skin tests. Allergy 63:138–139
Blanca M, Romano A, Torres MJ, Férnandez J, Mayorga C, Rodriguez J, Demoly P, Bousquet PJ, Merk HF, Sanz ML, Ott H, Atanasković-Marković M (2009) Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 64:183–193
Blanca M, Torres MJ, Garcia JJ, Romano A, Mayorga C, de Ramon E et al (1999) Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics. J Allergy Clin Immunol 103:918–924
Bonadonna P, Lombardo C, Bortolami O, Bircher A, Scherer K, Barbaud A et al (2012) Hypersensitivity to proton pump inhibitors: Diagnostic accuracy of skin tests compared to oral provocation test. J Allergy Clin Immunol 130:547–549
Bousquet J, Heinzerling L, Bachert C, Papadopoulos NG, Bousquet PJ, Burney PG et al (2012) Practical guide to skin prick tests in allergy to aeroallergens. Allergy 67:18–24
Brajon D, Menetre S, Waton J, Poreaux C, Barbaud A (2014) Non-irritant concentrations and amounts of active ingredient in drug patch tests. Contact Dermatitis 71:170–175
Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB et al (2013) ENDA/EAACI Drug Allergy Interest Group. Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 68:702–712
Brockow K, Romano A, Aberer W, Bircher AJ, Barbaud A, Bonadonna P et al (2009) Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study. Allergy 64:234–241
Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P (2002) General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 57:45–51
Brož P, Harr T, Hecking C, Grize L, Scherer K, Jaeger KA, Bircher AJ (2012) Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin. Allergy 67:647–652
Conilleau V, Dompmartin A, Michel M, Verneuil L, Leroy D (2000) Photoscratch testing in systemic drug-induced photosensitivity. Photodermatol Photoimmunol Photomed 16:62–66
De Groot AC (2008) Patch testing. In: Test concentrations and vehicles for 4350 chemicals, 3rd edn. Acdegroot Publishing, Wapserveen, the Netherlands, p 456
Esser S, Jablonka R, Heinemann FM, Reuter S, Jaeger H, von Krosigk A, Schenk-Westkamp P, Schadendorf D, Horn PA, Lindemann M (2012) Detection of abacavir hypersensitivity by ELISpot method. Inflamm Allergy Drug Targets 11:227–234
Ewan PW, Dugué P, Mirakian R, Dixon TA, Harper JN, Nasser SM (2010) BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy 40:15–31
Fernández TD, Ariza A, Palomares F, Montañez MI, Salas M, Martín-Serrano A, Fernández R, Ruiz A, Blanca M, Mayorga C, Torres MJ (2016) Hypersensitivity to fluoroquinolones: The expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone. Medicine (Baltimore) 95:e3679
Fréling E, Peyrin-Biroulet L, Poreaux C, Morali A, Waton J, Schmutz JL et al (2015) IgE antibodies and skin tests in immediate hypersensitivity reactions to infliximab in inflammatory bowel disease: impact on infliximab retreatment. Eur J Gastroenterol Hepatol 27:1200–1208
Fu M, Gao Y, Pan Y, Li W, Liao W, Wang G, Li C, Li C, Gao T, Liu Y (2012) Recovered patients with Stevens-Johnson syndrome and toxic epidermal necrolysis maintain long-lived IFN-γ and sFasL memory response. PLoS One 7:e45516
Gomes E, Pichler W, Demoly P et al (2004) The drug ambassador project: the diversity of diagnostic procedures for drug allergy around. Europe J World Allergy Organ 17:1–10
Gonçalo M, Ferguson J, Bonevalle A, Bruynzeel DP, Giménez-Arnau A, Goossens A et al (2013) Photopatch testing: recommendations for a European photopatch test baseline series. Contact Dermatitis 68:239–243
Guyot-Caquelin P, Granel F, Kaminsky MC, Trechot P, Schmutz JL, Barbaud A (2010) False positive results can occur on delayed reading of intradermal tests with cisplatin. J Allergy Clin Immunol 125:1410–1411
Hjortlund J, Mortz CG, Skov PS, Bindslev-Jensen C (2013) Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge. Allergy 68:1057–1064
Indradat S, Veskitkul J, Pacharn P, Jirapongsananuruk O, Visitsunthorn N, Indradat S (2016) Provocation proven drug allergy in Thai children with adverse drug reactions. Asian Pac J Allergy Immunol 34:59–64
Johansen JD, Aalto-Korte K, Agner T, Andersen KE, Bircher A, Bruze M et al (2015) European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice. Contact Dermatitis 73:195–221
Kleinhans M, Linzbach L, Zedlitz S, Kaufmann R, Boehncke WH (2002) Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation. Contact Dermatitis 47:100–102
Kuyucu S, Mori F, Atanaskovic-Markovic M, Caubet JC, Terreehorst I, Gomes E et al (2014) Hypersensitivity reactions to non-betalactam antibiotics in children: an extensive review. Pediatr Allergy Immunol 25:534–543
Leguy-Seguin V, Jolimoy G, Coudert B, Pernot C, Dalac S, Vabres P et al (2007) Diagnostic and predictive value of skin testing in platinum salt hypersensitivity. J Allergy Clin Immunol 119:726–730
Lerondeau B, Trechot P, Waton J, Poreaux C, Luc A, Schmutz JL, Paris C, Barbaud A (2016) Analysis of cross-reactivity among radiocontrast media in 97 hypersensitivity reactions. J Allergy Clin Immunol 137:633–635
Lobera T, Audícana MT, Alarcón E, Longo N, Navarro B, Muñoz D (2010) Allergy to quinolones: low cross-reactivity to levofloxacin. J Investig Allergol Clin Immunol 20:607–611
Martin M, Wurpts G, Ott H, Baron JM, Erdmann S, Merk HF, Sachs B (2010) In vitro detection and characterization of drug hypersensitivity using flow cytometry. Allergy 65:32–39
Mayorga C, Andreu I, Aranda A, Doña I, Montañez MI, Blanca-Lopez N, Ariza A, Nuin E, Blanca M, Miranda MA, Torres MJ (2013) Fluoroquinolone photodegradation influences specific basophil activation. Int Arch Allergy Immunol 160:377–382
Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P, Rodrigues-Cernadas J, Vultaggio A, Brockow K, Caubet JC, Makowska J, Nakonechna A, Romano A, Montañez MI, Laguna JJ, Zanoni G, Gueant JL, Oude Elberink H, Fernandez J, Viel S, Demoly P, Torres MJ, In vitro tests for Drug Allergy Task Force of EAACI Drug Interest Group (2016) In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 71:1103–1134
Mertes PM, Laxenaire MC, Lienhart A, Aberer W, Ring J, Pichler WJ, Demoly P (2005) Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol 15:91–101
Mertes PM, Malinovsky JM, Jouffroy L, Working Group of the SFAR and SFA, Aberer W, Terreehorst I, Brockow K, Demoly P, ENDA; EAACI Interest Group on Drug Allergy (2011) Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 21:442–453
Mori F, Barni S, Pucci N, Rossi E, Azzari C, de Martino M, Novembre E (2010) Sensitivity and specificity of skin tests in the diagnosis of clarithromycin allergy. Ann Allergy Asthma Immunol 104:417–419
Patel A, Bahna SL (2015) Immediate hypersensitivity reactions to corticosteroids. Ann Allergy Asthma Immunol 115:178–182
Perrin-Lamarre A, Petitpain N, Trechot P, Cuny JF, Schmutz JL, Barbaud A (2010) Toxidermies aux glycopeptides. Résultats du bilan immuno-allergologique dans une série de huit cas. Ann Dermatol Venereol 137:101–105
Phatharacharukul P, Klaewsongkram J (2013) A case of sulfasalazine-induced hypersensitivity syndrome confirmed by enzyme-linked immunospot assay. Allergy Asthma Immunol Res 5:415–417
Poreaux C, Bronowicki JP, Debouverie M, Schmutz JL, Waton J, Barbaud A (2014) Managing generalized interferon-induced eruptions and the effectiveness of desensitization. Clin Exp Allergy 44:756–764
Porebski G, Pecaric-Petkovic T, Groux-Keller M, Bosak M, Kawabata TT, Pichler WJ (2013) In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test. Clin Exp Allergy 43:1027–1037
Romano A, Gaeta F, Valluzzi RL, Zaffiro A, Caruso C, Quaratino D (2014) Natural evolution of skin-test sensitivity in patients with IgE-mediated hypersensitivity to cephalosporins. Allergy 69:806–809
Santiago F, Gonçalo M, Vieira R, Coelho S, Figueiredo A (2010) Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermatitis 62:47–53
Scherer K, Tsakiris DA, Bircher AJ (2008) Hypersensitivity reactions to anticoagulant drugs. Curr Pharm Des 14:2863–2873
Soria A, Baeck M, Goossens A, Marot L, Duveille V, Derouaux AS et al (2011) Patch, prick or intradermal tests to detect delayed hypersensitivity to corticosteroids? Contact Dermatitis 64:313–324
Tang YH, Mockenhaupt M, Henry A, Bounoua M, Naldi L, Le Gouvello S, Bensussan A, Roujeau JC (2012) Poor relevance of a lymphocyte proliferation assay in lamotrigine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis. Clin Exp Allergy 42:248–254
Torres MJ, Romano A, Celik G, Demoly P, Khan DA, Macy E, Park M, Blumenthal K, Aberer W, Castells M, Barbaud A, Mayorga C, Bonadonna P (2017) Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America. Clin Transl Allergy 7:7. https://doi.org/10.1186/s13601-017-0144-0
Ulrich G, Schmutz JL, Trechot P, Commun N, Barbaud A (2004) Sensitization to petrolatum: an unusual cause of false-positive drug patch-tests. Allergy 59:1006–1009
Waton J (2011) L’allergie à l’insuline: mise au point. Rev Fr Allergologie 51:336–342
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Barbaud, A. (2019). In Vitro and In Vivo Tests in Cutaneous Adverse Drug Reactions. In: Shear, N., Dodiuk-Gad, R. (eds) Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions. Adis, Singapore. https://doi.org/10.1007/978-981-13-1489-6_18
Download citation
DOI: https://doi.org/10.1007/978-981-13-1489-6_18
Published:
Publisher Name: Adis, Singapore
Print ISBN: 978-981-13-1488-9
Online ISBN: 978-981-13-1489-6
eBook Packages: MedicineMedicine (R0)